Sign in
4

Changes in Ownership

PharmaCyte Biotech, Inc. Filed Acc 0001683168-26-002632

Options or other derivatives

  • Director acquired 119,170 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

WALKER WAYNE REMELL · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-31 Grant or award : show line 1 in the form Stock Option (Right to Buy) +119,170 119,170 D
Loading xslF345X06/ownership.xml…